EXAGEN INC. - Common Stock, par value $0.001 per share (XGN)

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
22,037,221
Total 13F shares
6,113,043
Share change
-357,248
Total reported value
$25,061,829
Put/Call ratio
582%
Price per share
$4.10
Number of holders
40
Value change
-$538,491
Number of buys
15
Number of sells
16

Institutional Holders of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) as of Q4 2024

As of 31 Dec 2024, EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) was held by 40 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,113,043 shares. The largest 10 holders included RTW INVESTMENTS, LP, TORONTO DOMINION BANK, SILVERCREST ASSET MANAGEMENT GROUP LLC, VANGUARD GROUP INC, MORGAN STANLEY, PERKINS CAPITAL MANAGEMENT INC, Driehaus Capital Management LLC, Stonepine Capital Management, LLC, KENNEDY CAPITAL MANAGEMENT LLC, and RENAISSANCE TECHNOLOGIES LLC. This page lists 40 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.